Eugene

[email protected]

LATEST

Alexion To Acquire Wilson Therapeutics for $855 Million
By

By
Alexion Pharmaceuticals, a New Haven, Connecticut-based pharmaceutical company, has agreed to acquire Wilson Therapeutics, a Stockholm, Sweden-headquartered biopharmaceutical company that develops therapies for patients with rare copper-mediated disorders, for $855…

Frontage Labs Acquires Former CRO Business of Ricerca
By

By
Frontage Laboratories, an Exton, Pennsylvania-headquartered contract research organization, has acquired Concord Biosciences, which was the company formed from the contract research activities of Ricerca Biosciences, a CRO and contract development…

LGM Pharma Announces New CEO
By

By
LGM Pharma, an active pharmaceutical ingredient supplier, has announced that Dr. Prasad S. Raje, PhD has been named Chief Executive Officer (CEO). In this capacity, Dr. Raje will be heading…

Celltrion Receives FDA Complete Response Letter for Biosimilars of Two Roche Blockbuster Drugs
By

By
Celltrion, an Incheon, South Korea-based life-sciences company, has received Complete Response Letters (CRLs) from the US Food and Drug Administration (FDA) regarding the company’s biologics license applications (BLA) for proposed…

FDA Issues Warning Letter to Tris Pharma Concerning Pfizer ADHD Drug
By

By
The US Food and Drug Administration (FDA) has issued a Warning Letter to Tris Pharma, a Monmouth Junction, New Jersey-based specialty pharmaceutical company, for violations of current good manufacturing practices…

Lonza Opens Cell-and-Gene-Therapy Mfg Facility in Houston
By

By
Lonza has opened a new 300,000-square-foot dedicated cell-and-gene-therapy manufacturing facility in Pearland, Texas, part of the Greater Houston area. Lonza Houston will serve as a center of excellence for cell-and-gene-therapy…

Ferring Pharmaceuticals To Acquire Microbiome Drug Company Rebiotix
By

By
Ferring Pharmaceuticals, a Saint-Prex, Switzerland-headquartered biopharmaceutical company, has agreed to acquire Rebiotix, a Roseville, Minnesota-headquartered clinical-stage biopharmaceutical company focused on developing treatments involving the human microbiome. The most advanced investigational…

Famar Appoints President
By

By
Famar, a contract development and manufacturing organization (CDMO), has appointed Bruno Biscaro as President, North America. In this role, Biscaro will lead all Famar’s business activities and operations within the…

Thermo Fisher Forms Pharmagenomics Center of Excellence
By

By
Thermo Fisher Scientific and the University of Pittsburgh have established a new Pharmacogenomics (PGx) Center of Excellence that combines technology in genomics, bioinformatics, implementation science, medication-response phenotyping, and education. The…

Therapure Launches Biologics Division
By

By
Therapure Biopharma, a Mississauga, Ontario, Canada-based biologics manufacturer, has launched its plasma products and technology division as Evolve Biologics, focused on plasma-derived therapeutics for patients with rare chronic diseases and…